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miR-1792, miR-106b25, and miR-106a363 be-
long to a family of highly conserved miRNA clusters.
Amplification and overexpression of miR-1792 is
observed in human cancers, and its oncogenic prop-
erties have been confirmed in amousemodel of B cell
lymphoma. Herewe show thatmice deficient formiR-
1792 die shortly after birth with lung hypoplasia and
a ventricular septal defect. The miR-1792 cluster is
also essential for B cell development. Absence of
miR-1792 leads to increased levels of the proapop-
totic protein Bim and inhibits B cell development at
the pro-B to pre-B transition. Furthermore,while abla-
tion of miR-106b25 or miR-106a363 has no obvi-
ous phenotypic consequences, compound mutant
embryos lacking both miR-106b25 and miR-1792
die at midgestation. These results provide key in-
sights into the physiologic functions of this family of
microRNAsandsuggest a linkbetween theoncogenic
properties of miR-1792 and its functions during B
lymphopoiesis and lung development.
INTRODUCTION
Vertebrate embryonic development is a carefully orchestrated
process that requires execution of tightly regulated gene-ex-
pression programs. MicroRNAs (miRNAs) constitute a class of
small (21–24 nucleotide) noncoding RNAs that reduce translation
and stability of target mRNAs through sequence-specific inter-
action with their 30-untranslated region (Bagga et al., 2005;
Bartel, 2004; Lim et al., 2005). It is becoming increasingly clear
that miRNAs play a crucial role in vertebrate development, as
attested by the early embryonic lethality of mice with defects inthe miRNA biogenesis pathway (Abbott et al., 2005; Bernstein
et al., 2003; Liu et al., 2004). MicroRNAs could act either by reg-
ulating a specific set of critical developmental genes or by rein-
forcing gene-expression programs through suppression of tran-
scriptional noise (Bartel and Chen, 2004; Hornstein and
Shomron, 2006; Yekta et al., 2004).
A close link exists between deregulation of developmental
programs and tumorigenesis, and a growing body of evidence
indicates that altered expression of miRNAs is involved in the
pathogenesis of human cancers (Costinean et al., 2006; Croce
and Calin, 2005; Esquela-Kerscher and Slack, 2006; Hammond,
2006; Johnson et al., 2005; Kumar et al., 2007; Lu et al., 2005;
Mayr et al., 2007; Voorhoeve et al., 2006). In this context, studies
in mouse and human cells have led to the identification of the
miR-1792 cluster (also known as Oncomir-1) as a potential
oncogene. It consists of six miRNAs that are processed from
a common precursor transcript and can be grouped in four fam-
ilies based on their ‘‘seed’’ sequence (Figures 1A and 1B). A role
for miR-1792 in the pathogenesis of human cancers is sug-
gested by its frequent amplification and overexpression in dif-
fuse large B cell lymphomas (Ota et al., 2004) and in other tumor
types, including small cell lung cancer (Hayashita et al., 2005;
Matsubara et al., 2007). Additionally, miR-1792 has been
shown to cooperate with c-Myc in a mouse model of B cell lym-
phoma (He et al., 2005) and to stimulate proliferation of the lung
epithelium (Lu et al., 2007). Further evidence indicates that miR-
1792 can also affect tumor angiogenesis (Dews et al., 2006)
and the expression of members of the E2F family of oncogenic
transcription factors (O’Donnell et al., 2005; Sylvestre et al.,
2006; Woods et al., 2006). Very little is known, however, regard-
ing the physiologic functions of this cluster in vertebrates.
The functional analysis of miR-1792 is complicated by the
existence of two paralogs: miR-106a363 and miR-106b25.
It appears likely that the three clusters originated via a series of
duplication and deletion events during early vertebrate evolution
(Tanzer and Stadler, 2004). The miR-106a363 locus maps toCell 132, 875–886, March 7, 2008 ª2008 Elsevier Inc. 875
Figure 1. Generation of Targeted Deletions in miR-17w92, miR-106bw25, and miR-106aw363
(A) Schematic representation of the three miRNA clusters. Pre-miRNAs are indicated as color-coded boxes. Black boxes correspond to the mature miRNA. The
color code identifies miRNAs with the same seed sequence.
(B) Sequence comparison of miRNAs expressed from the three miRNA clusters. miRNAs with the same seed sequence (bold) are grouped together and color-
coded according to (A).
(C) Targeting scheme for the deletion of miR-106b25. Mcm-7 exons are represented by black boxes. The mature miRNAs are represented by colored boxes.
(D) Genotyping PCR performed on tail DNA showing germline transmission of the targeted miR-106b25 alleles.
(E) Targeting scheme for the deletion of miR-106a363.
(F) Genotyping PCR performed on tail DNA showing germline transmission of the targeted miR-106a363 allele.
(G) Targeting scheme for the deletion of miR-1792.
(H) Genotyping PCR performed on DNA extracted from E13.5 embryos showing germline transmission of the miR-1792-Dneo allele.
(I) Genotyping PCR performed on DNA extracted from miR-1792fl/fl;Cre-ERT2+ mouse embryo fibroblasts. Cre-mediated deletion of miR-1792 was assessed
5 days after infection with Cre-expressing recombinant Adenoviruses (Ad-Cre) or after treatment with 4-hydroxytamoxifen.876 Cell 132, 875–886, March 7, 2008 ª2008 Elsevier Inc.
Figure 2. Deletion of miR-106aw363 or miR-106bw25 Results in Viable and Fertile Mice
(A) Genotypes of mice from miR-106b25+/Dneo and miR-106b25+/D intercrosses.
(B) RPAs on total RNA extracted from wild-type and miR-106b25D/D adult tissues.
(C) RT-PCR on RNA extracted from miR-106b25D/D and wild-type lungs and livers. Primers designed to amplify the junctions of exons 13–14 were used to de-
termine whether the deletion of miR-106b25 from intron 13 affects splicing between these two exons. Amplification of the junction between exons 2 and 3 was
used as control.
(D) MCM-7 western blot on whole cell lysates from wild-type and miR-106b25Dneo/Dneo mouse embryo fibroblasts.
(E) Genotypes of mice from miR-106a363D/Y X miR-106a363+/D crosses.
(F) Genotypes of mice from miR-1792+/Dneo intercrosses determined at the indicated gestation stages. The asterisk indicates that all miR-1792Dneo/Dneo new-
born mice died soon after birth.
(G) RPAs on total RNA from E13.5 embryos with the indicated genotypes.chromosome X in humans and mice and consists of six miRNAs
(Figure 1A). The miR-106b25 cluster is located on mouse chro-
mosome 5 (chromosome 7 in humans) in the 13th intron of the
DNA-replication gene Mcm7 and consists of three miRNAs
(Figure 1A). Because miR-106a363 and miR-106b25 contain
miRNAs that are highly similar, and in some cases identical, to
those encoded by miR-1792 (Figure 1B), it is possible that
they regulate a similar set of genes and have overlapping func-
tions. Here we report the generation and initial characterization
of mice deficient for each of these three miRNA clusters.
RESULTS
Expression Pattern of miR-17w92 and Its Two Paralogs
To determine the expression patterns of the miR-1792, miR-
106b25, and miR-106a363 clusters we performed RNase
protection assays (RPA) on a panel of murine tissues and cells.
This technique was preferred to northern blots because it has
higher sensitivity and is capable of discriminating between sim-ilar miRNAs (Figures 2B, 2G, and S1). These experiments
revealed that members of the miR-1792 and miR-106b25
clusters have similar expression pattern in the adult mouse, be-
ing detectable in most tissues (Figure S1). In contrast, we have
not been able to detect expression of members of the miR-
106a363 cluster in the tissue tested (Figure S1). Expression
of members of this cluster was undetectable by RPA even in
murine embryonic stem (ES) cells and in midgestation embryos,
where miR-1792 and miR-106b25 are abundantly expressed
(Figure S1; data not shown).
Generation and Characterization
of miR-106bw25-Deficient Mice
The miR-106b25 cluster is located in the 13th intron of the pro-
tein coding gene Mcm7. To reduce the risk of interfering with
transcription and processing of the surrounding gene, the target-
ing construct was designed to replace the miR-106b25 cluster
with a neomycin-resistance (Neo) cassette flanked by frt sites
(miR-106b25Dneo) (Figure 1C). This strategy allowed theCell 132, 875–886, March 7, 2008 ª2008 Elsevier Inc. 877
subsequent removal of the Neo cassette by crossing the chime-
ric animals to flpe-expressing transgenic mice (Rodriguez et al.,
2000), thus generating the miR-106b25D allele (Figure 1C).
miR-106b25+/D and miR-106b25D/D mice were viable, fertile,
and showed no obvious abnormalities (Figure 2A). In contrast,
we did not obtain any mutant animal homozygous for the miR-
106b25Dneo allele (Figure 2A). This observation suggests that
if left in place the Neo cassette interferes with the expression
of Mcm7 and highlights the importance of carefully designing
the targeting strategy for intronic miRNAs. All results presented
hereafter derive from the use of the miR-106b25D allele. Suc-
cessful deletion of miR-106b25 was confirmed by RNAse
protection assay and qPCR performed on total RNA extracted
from wild-type and mutant midgestation embryos and adult tis-
sues (Figure 2B; data not shown). Importantly, the expression
and splicing of Mcm7 RNA was identical in wild-type and miR-
106b25D/D animals (Figures 2C and 2D).
Generation and Characterization
of miR-106aw363-Deficient Mice
A similar strategy was employed to delete miR-106a363 on the
X chromosome (Figures 1E and 1F). This allele was generated
before the identification of miR-363 as a member of the cluster
and, as such, part of this miRNA is still present in the targeted
allele. However, because the 50 flanking region of miR-363 is de-
leted, it is unlikely that this miRNA will be successfully processed
from the targeted allele. Unfortunately, because miR-106a363
expression is undetectable by either RPA or qPCR we have not
been able to verify whether this is indeed the case.
Mice lacking the miR-106a363 cluster were viable, repro-
duced efficiently, and had no obvious abnormalities (Figure 2E).
Mice homozygous or hemizygous for the miR-106a363D or
themiR-106a363Dneo alleles were phenotypically indistinguish-
able (data not shown).
Generation of miR-17w92-Deficient Mice
To delete miR-1792, a construct was designed in which this
cluster is flanked by loxP sites and followed by an frt-Neo-frt cas-
sette (Figure 1G,miR-1792 2f/2l). After successful homologous
recombination in ES cells and germline transmission of the tar-
geted allele, the cluster was deleted in vivo by crossing to a Cre
deletor mouse strain in which the Cre recombinase is expressed
under the control of the human beta actin promoter (Lewandoski
et al., 1997). The resulting allele will be referred to hereafter as
miR-1792Dneo (Figures 1G and 1H). An additional allele, miR-
1792D (Figures 1G and 1H), was generated by removing the
Neo cassette from the miR-1792Dneo allele via flpe-mediated
recombination. Mice homozygous for the miR-1792Dneo or the
miR-1792D allele were phenotypically indistinguishable. This
targeting strategy also allowed the generation of a conditional
(‘‘floxed’’) miR-1792 allele (miR-1792fl; Figures 1G and 1I)
via flpe-mediated deletion of the Neo cassette from miR-
17922frt/2lox mice. In mice and cells carrying the miR-1792fl
allele, Cre expression leads to efficient deletion of miR-1792
(Figures 1I and S2). As predicted, miR-1792fl/fl mice were
born at the expected Mendelian ratio, showed no obvious abnor-
malities (data not shown), and expressed normal levels of miR-
1792 (Figure S2; data not shown).878 Cell 132, 875–886, March 7, 2008 ª2008 Elsevier Inc.Early Postnatal Lethality of miR-17w92-Deficient Mice
miR-1792+/Dneo mice were born at the expected Mendelian ra-
tio, were viable, fertile, and only slightly smaller than their wild-
type littermates (Figures 2F and 3B; data not shown). In contrast,
intercrosses between miR-1792+/Dneo mice failed to produce
viable miR-1792Dneo/Dneo animals. Viable miR-1792Dneo/Dneo
embryos were recovered throughout gestation at about the
expected Mendelian frequency, and the majority of them reached
birth (Figure 2F). However,miR-1792Dneo/Dneo newborns invari-
ably died within minutes after birth, and no miR-1792-deficient
mice were observed at later time points (Figure 2F).
Deletion of miR-1792was verified by RPA and qPCR on total
RNA from wild-type and mutant E13.5 embryos (Figure 2G; data
not shown). As predicted, miR-17-5p, miR-18a, miR-20a, miR-
19a, and miR-19b-1 were undetectable in miR-1792Dneo/Dneo
embryos (Figure 2G), and their expression in heterozygous
mutant embryos was roughly halved compared to wild-type
controls. Interestingly, the signal for miR-92 miRNA was greatly
reduced, but not abolished, in the miR-1792Dneo/Dneo embryos.
Because these embryos lack the entire miR-1792 locus, this
observation is most likely explained by hybridization of the
probes to identical or nearly identical microRNAs expressed
from one of the paralogs.
Lung Hypoplasia and Ventricular Septal Defect
in miR-17w92-Deficient Mice
Macroscopically, homozygous mutant embryos were easily dis-
tinguished from wild-type littermates by embryonic day 13.5
(E13.5) because of their smaller size (Figure 3A). At E18.5, the
weight of miR-1792 null embryos was 60% that of wild-
type littermates (Figure 3B).
To determine the cause of the postnatal lethality, miR-1792
null late-gestation embryos (E18.5–P0) were subjected to nec-
ropsy and histological examination. Macroscopically, the most
significant phenotype in the miR-1792 null embryos was the
presence of severely hypoplastic lungs (Figure 3C). Despite the
smaller size, histological examination did not reveal any specific
branching defect or other obvious developmental abnormalities
(data not shown). Interestingly, it has been recently reported that
overexpression of miR-1792 in the developing lung can
increase proliferation and impair differentiation of the lung
epithelium (Lu et al., 2007).
Although the hearts of miR1792-deficient and wild-type
embryos were of comparable size, mutant E18.5 embryos pre-
sented a clear ventricular septal defect (Figure 3D). This pheno-
type occurred in all mutant embryos (n = 4) that were subjected
to serial sectioning. Other organ systems examined, including
the placenta, appeared histologically normal.
miR-17w92 Is Essential for Fetal B Cell Development
The role of miR-1792 in the pathogenesis of B cell lymphomas
led us to investigate its function in normal B cell development.
Mice deficient for miR-106a363 or miR-106b25, as well as
miR-1792+/Dneo mice, had normal numbers of circulating B
cells and bone marrow B cell progenitors (Figure S3). We next
examined the effects of deletion of miR-1792 on B cell devel-
opment. Because by midgestation the liver is the primary hema-
topoietic organ in mice, we performed flow cytometric analysis
Figure 3. Characterization of miR-17w92-Deficient Mice
(A) Macroscopic appearance of wild-type and miR-1792-deficient embryos at various developmental stages.
(B) Body mass of wild-type (WT), heterozygous (HET) and miR-1792 null (KO) E18.5 embryos. The boxes indicate the 25th–75th percentile range. The horizontal
lines represent the median, and the error bars indicate the lowest and highest values. P values were calculated using the two-tailed t test.
(C) Macroscopic appearance of wild-type and miR-1792-deficient lungs and hearts from E17.5 embryos. Notice the markedly hypoplastic lungs in miR-1792
null embryos.
(D) Hematoxylin-eosin staining of comparable transverse sections through the hearts of E18.5 wild-type andmiR-1792 null embryos. The arrow indicates a ven-
tricular septal defect.
(E) Flow cytometry plots of fetal liver cells from E18.5 wild-type and mutant embryos showing a marked reduction of B220+;CD43;IgM pre-B cells in mice
lacking miR-1792. The results are representative of three independent experiments.
(F) Annexin V staining showing increased apoptosis inmiR-1792-deficient fetal liver B cell progenitors (blue) compared to wild-type control (red). The right panel
shows the same analysis performed on B220-negative cells.of fetal liver cells from control and miR-1792Dneo/Dneo embryos.
Although homozygous mutant fetal livers contained fewer total
cells than controls at E14.5, the frequency of hematopoietic
stem cells was comparable to wild-type controls and the fre-
quency of early B cell progenitors was only slightly reduced
(Figure S4). In contrast, at E18.5, miR-1792-deficient fetal
livers had a greatly reduced percentage and absolute number
of pre-B cells (Figures 3E). This reduction in pre-B cells in the
mutant embryos was associated with increased apoptosis, as
measured by staining with Annexin V (Figure 3F). Importantly,
the increase in apoptosis was specific to the B cell compartment,
since levels of apoptosis in non-B cells were comparable in
mutant and control fetal livers (Figure 3F). Higher levels of apo-
ptosis were not detected in other organs of the embryos (data
not shown).
miR-17w92 Is Essential for Adult B Cell Development
To study adult B cell development and determine whether the
defect in B cell development was cell autonomous, we reconsti-
tuted the hematopoietic system of lethally irradiated mice withfetal liver cells from wild-type or miR-1792Dneo/Dneo E14.5
embryos (Figure 4A). Eight to ten weeks after transplantation,
donor red blood cells, granulocytes, and monocytes were pres-
ent at similar frequencies in the blood of mice reconstituted with
wild-type or miR-1792Dneo/Dneo hematopoietic cells (Figures
4B and 4C). Similar numbers of granulocytes and monocytes
were also present in the spleens and bone marrows from both
groups of recipient mice (Figure S5). In contrast, the number of
circulating lymphocytes was greatly reduced in mice reconsti-
tuted withmiR-1792-deficient hematopoietic cells due to a sig-
nificant and specific reduction of circulating B cells (Figures 4C–
4F). The percentage and absolute number of splenic B cells were
also significantly reduced in mice reconstituted withmiR-1792-
deficient hematopoietic cells (Figure 4G). Interestingly, in all
mice, splenic B cells had a comparable cell-surface phenotype,
and we observed similar relative (but not absolute) numbers of
transitional and mature B cells (Figure 4H). Splenic marginal
zone, follicular, and newly formed B cells, as well as peritoneal
B1a and B1b cells were all reduced by miR-1792-deficiency
(Figure S6).Cell 132, 875–886, March 7, 2008 ª2008 Elsevier Inc. 879
Figure 4. Deletion of miR-17w92 Impairs Adult B Cell Development
(A) Schematic of the reconstitution experiment.
(B) Total number of circulating RBC per mm3 of blood in mice reconstituted with wild-type (black) or miR-1792-deficient (gray) fetal livers 8 weeks posttrans-
plantation. Error bar indicates +1 SD. The average of seven wild-type and eight miR-1792-deficient mice is shown.
(C) Differential white blood cell counts in mice reconstituted with wild-type (black) andmiR-1792-deficient (gray) fetal livers. PMNs, polymorphonucleates. Error
bar is +1 SD, n = 7 wild-type and 8 miR-1792 mutants.
(D) Representative flow cytometry plot showing reduction of B220+ B cells in the blood of mice reconstituted with miR-1792-deficient fetal liver cells.
(E) Dot plot showing the number of circulating B cells in reconstituted mice. Horizontal bars in red indicate the median value for each genotype.
(F) Flow cytometry plot of T cells in the periphery of reconstituted mice. On representative example per genotype is shown.
(G) Flow cytometry plot of spleen cells stained for CD11b and B220, showing a reduction in splenic B cells in mice reconstituted with miR-1792-deficient cells.
(H) Flow cytometry plot on B-220-positive splenic B cells stained with IgM and IgD to determine the relative fraction of transition (T1 and T2) and mature B cells.miR-17w92 Regulates B Cell Survival
To characterize the effect of miR-1792 deficiency on early B
cell development more fully, we analyzed the bone marrow
from mice reconstituted with mutant or wild-type cells. B cells
develop through well-characterized stages that are distin-
guished by expression of specific cell-surface markers (fractions
A to F [Hardy et al., 1991]). B220+CD43+ pro-B cells (fraction A–
C) were only slightly reduced in the bone marrow of mice trans-
planted withmiR-1792-deficient fetal liver cells (Figures 5A and
5B). The subsets of pro-B cells were also largely unaffected by
the absence of miR-1792 (Figure 5C). In contrast, the percent-
ages of pre-B cells (B220+CD43IgM) and later stages (frac-
tions E and F) were substantially reduced in mice transplanted
with miR-1792-null fetal liver cells (Figures 5A and 5B).
To confirm the role of miR-1792 in early B cell development,
we took advantage of the conditional miR-1792 allele. To
achieve conditional ablation of miR-1792 in hematopoietic
cells in vivo, miR-1792fl/fl mice were crossed to Mx-Cre trans-
genic mice (Kuhn et al., 1995). In these mice the Cre transgene is880 Cell 132, 875–886, March 7, 2008 ª2008 Elsevier Inc.expressed under the control of the inducible Mx1 promoter,
which can be activated in the hematopoietic compartment in
response to treatment with polyinosinic-polycytidylic acid
(pI:pC) double-stranded RNA. Two-month-old mice were in-
jected intraperitoneally (i.p.) with pI:pC and examined 4 weeks
later. As shown in Figure S2, efficient deletion of miR-1792
was accompanied by a marked reduction of pre-B cells in the
bone marrow of miR-1792fl/fl;Mx-Cre-positive mice but not in
control animals.
The reduced number of pre-B cells could be due to either
enhanced cell death or to reduced proliferation of miR-1792-
deficient pro- or pre-B cells. Cell-cycle analysis of the various
stages of B cell development showed no differences in the
cell-cycle profiles of pro- and pre-B cells (Figure S7). In contrast,
pro-B cell death was increased in the absence of miR-1792, as
determined by DAPI exclusion and Annexin V staining (Figure 5D;
data not shown). The increase in apoptosis was specific to the
early stages of B cell development, as the viability of immature
B cells and mature B cells in the bone marrow was not
significantly affected by the deletion of miR-1792 (Figure 5D;
data not shown). Analysis of immunoglobulin heavy chain rear-
rangement in control and miR-1792 null pro-B cells showed
that DH to JH recombination occurs normally, while the next
step (VH-to-DJH rearrangement) is somewhat less efficient than
in controls (data not shown). These results indicate that miR-
1792 plays a critical role in promoting the survival of early B
cell progenitors. Consistent with this interpretation, the expres-
sion of miRNAs belonging to the miR-1792 cluster appears to
be tightly regulated during B cell development, reaching a maxi-
mum at the pre-B cell stage and then rapidly returning to basal
levels at later stages (Figure 5E).
Regulation of the Proapoptotic Protein Bim
by miR-17w92
The data presented above suggest the possibility that members
of the miR-1792 cluster regulate survival of early B cell progen-
itors by repressing the expression of proapoptotic genes at the
pro- to pre-B cell transition. We therefore surveyed the list of
putative miR-1792 target genes predicted by the TargetScan
software (http://www.targetscan.org) to identify genes that
could mediate this phenotype. TargetScan predicts miRNA
targets based on a series of criteria that include sequence com-
plementarity between the miRNA and the 30UTR, evolutionary
conservation, position of the binding site within the 30UTR, and
local ‘‘AU’’ content (Grimson et al., 2007; Lewis et al., 2003). Sev-
eral known proapoptotic genes, including PTEN, E2F1, and
Figure 5. miR-17w92 Regulates Early B Cell
Survival
(A) Representative flow cytometry plots of bone mar-
row cells from mice reconstituted with wild-type or
miR-1792-deficient fetal liver cells.
(B) Percentage of pro-B and pre-B cells in reconsti-
tuted mice. The median (red bars) and the p values
are indicated.
(C) Representative flow cytometry plots showing rela-
tive proportion of fractions A–C pro-B cells in the bone
marrow of reconstituted mice.
(D) Histogram overlays of Annexin V staining of pro-B
(left panel) and pre-B cells (right panel), showing in-
creased apoptosis of pro-B cells in the bone marrow
of mice reconstituted with miR-1792-deficient fetal
liver cells. The analysis was performed on the bone
marrow of mice reconstituted with wild-type (red line)
or miR-1792-deficient (blue line) fetal livers.
(E) qPCR analysis of miR-1792 and miR-106b25
expression during B cell development. Pro-, pre-, im-
mature, and mature B cells were sorted and their RNA
assayed for miR-20a and miR-93 expression. Data are
normalized to sno-142 expression.
Bcl2l11/Bim are predicted targets of miR-
1792. PTEN and E2F1 have been
previously validated (Novotny et al., 2007;
O’Donnell et al., 2005). Bim is a particularly
attractive candidate target of miR-1792
given its role in controlling lymphocyte apo-
ptosis and in suppressing Myc-induced B
cell lymphomagenesis (Bouillet et al., 1999, 2002; Egle et al.,
2004; Hemann et al., 2005; O’Connor et al., 1998).
The 30UTR of Bim contains four predicted binding sites for
members of the miR-1792 cluster and its paralogs
(Figure 6A). Two binding sites for miR-19 and miR-92 that are
located 42 nucleotides apart in the distal portion of the Bim
30UTR (Figure 6A) are of particular interest, as it has been shown
that closely spaced sites often act synergistically (Grimson et al.,
2007). We therefore examined whether Bim expression is
modulated by miR-1792. A significant increase of Bim protein
levels compared to controls was observed in miR-1792-defi-
cient pro- and pre-B cells from fetal livers (Figure 6B). Similarly,
we detected higher BIM levels in adult pre-B cells following
acute deletion of miR-1792 in hematopoietic cells in vivo
(Figure 6C). BIM upregulation was also observed in the lungs
of miR-1792 null late gestation embryos (Figure 6D). Next we
cloned a fragment of the Bim 30UTR spanning the closely
spaced miR-19/miR-92 binding sites downstream of the Renilla
luciferase coding sequence and compared its activity in HeLa
cells to an equivalent construct where the miR-19/miR-92
seed sites were mutated. These experiments demonstrated
that the presence of the two binding sites in the 30UTR confers
significant and reproducible repression (Figure 6E). Together,
these results indicate that Bim is a direct target of miR-1792
and suggest a possible mechanism through which deletion or
overexpression of miR-1792 affects B cell development and
lymphomagenesis.Cell 132, 875–886, March 7, 2008 ª2008 Elsevier Inc. 881
Functional Interaction between miR-17w92
and miR-106bw25
The occurrence of multiple, highly similar miRNAs is common in
animal genomes and raises the question of functional redun-
dancy and compensation. Given the similarity in sequence and
expression pattern among miRNAs expressed from miR-
1792 and miR-106b25 (Figures 1B, S1, and 5E), we decided
to investigate the consequences of simultaneous deletion of
these miRNA clusters in the mouse. Intercrosses between dou-
ble-heterozygous animals (miR-1792+/D;miR-106b25+/D) led
to the generation of viable miR-1792D/+;miR-106b25D/D
mice that could not be distinguished from wild-type controls.
In similar experiments including the miR-106a363D allele, we
also obtained viable and fertile miR-1792D/+;miR-106b25D/D;
miR-106a363D/y mice, thus demonstrating that a single
wild-type miR-1792 allele is compatible with normal mouse
development even in the absence of the two paralog clusters.
In contrast, neither double-knockout (miR-1792D/D;miR-
106b25D/D, hereafter indicated as DKO) nor triple-knockout
(miR-1792D/D;miR-106b25D/D;miR-106a363D/y, hereafter
referred to as TKO) animals were recovered at birth. Timed-mat-
ing experiments revealed that DKO and TKO embryos die before
Figure 6. Bim Regulation by miR-17w92
(A) Schematic representation of the 30UTR of Bim and the
predicted binding sites for members of the miR-1792
cluster and its paralogs.
(B) Detection of Bim expression by flow cytometry in miR-
1792+/Dneo and miR-1792Dneo/Dneo pro-B (upper
panels) and pre-B cells (lower panel) from E18.5 fetal
livers.
(C) Detection of Bim expression by western blotting in pre-
B cells from adult mice following conditional deletion of
miR-1792. miR-1792fl/fl (left lane) and miR-1792fl/fl;
Mx-Cre mice (right lane) were treated with pI:pC to induce
expression of the Cre transgene. Pre-B cells were sorted
and analyzed by western blotting 4 weeks after treatment.
(D) Detection of Bim expression by western blotting in
E18.5 lungs from wild-type and miR-1792Dneo/Dneo
embryos.
(E) Box plot of normalized relative luciferase activity of
wild-type and mutant Bim UTR constructs 24 and 48 hr
after transfection in HeLa cells. Data represent three inde-
pendent experiments performed in triplicate.
embryonic day 15 and exhibit a much more
severe phenotype compared to embryos lack-
ing miR-1792 alone (Figure 7A). Macroscopic
and microscopic examination of E13.5 and
E14.5 DKO embryos revealed edema and vas-
cular congestion (n = 3). This was associated
with severe cardiac developmental abnormali-
ties, consisting of defective ventricular and
atrial septation and thinner ventricles (Fig-
ure 7B). In addition, we observed areas of in-
tense staining for cleaved caspase 3, a marker
of apoptosis, in the fetal liver, the ventral horns
of the spinal cord, and the lateral ganglionic
eminences of DKO and TKO embryos, but not in controls or in
miR-1792Dneo/Dneo embryos (Figure 7C; data not shown).
These results provide genetic evidence that the miR-1792
and miR-106b25 clusters functionally cooperate in regulating
embryonic development and apoptosis in the mouse.
DISCUSSION
In the present study, we have investigated the biological
functions of the miR-1792 cluster and its two paralogs: miR-
106b25 and miR-106a363. We show that deletion of miR-
1792 leads to neonatal lethality and very specific defects in
the development of heart, lungs, and B cells. We also provide ge-
netic evidence of functional cooperation between related miRNA
clusters in the mouse by showing that concomitant deletion of
miR-106b25 and miR-1792 results in severe cardiac defects,
increased apoptosis, and embryonic death by midgestation.
Role of miR-17w92 in Heart and Lung Development
Cardiac development is a carefully regulated process that is
extremely susceptible to even small perturbations, as attested
by the high frequency of congenital cardiac malformations in882 Cell 132, 875–886, March 7, 2008 ª2008 Elsevier Inc.
humans and in genetically modified mice (Chen and Fishman,
2000; Hoffman et al., 2004). In mice, closure of the ventricular
septum is normally completed by gestation day 14.5 (Webb
et al., 1998), and several mutations are known to interfere with
Figure 7. Functional Cooperation between miR-17w92 and miR-
106bw25
(A) Effects of compound mutations of miR-1792, miR-106b25, and miR-
106a363 on embryonic development. E14.5 embryos with the indicated
genotypes are shown. DKO = miR-1792D/D;miR-106b25D/D; TKO = miR-
1792D/D;miR-106b25D/D;miR-106A363D/y.
(B) Representative transverse sections of E14.5 mice showing the presence of
ventricular (arrow) and atrial (asterisk) septal defects in DKO and TKO embryos
(upper panels). Lower panels show a higher magnification of the lateral wall of
the left ventricle. Notice the thinner wall in double and triple mutant embryos.
The black bars correspond to 500 mm (upper panels) and 100 mm (lower
panels). The controls were a miR-1792+/+;miR-106b25+/D;miR-
106a363D/y (left) and a miR-1792+/D;miR-106b25+/D;miR-106a363wt
(right) mouse.
(C) Cleaved caspase 3 immunostaining of sections from an E14.5 DKO miR-
1792D/D;miR-106b25D/D (DKO) embryo, and a miR-1792+/+; miR-
106b25D/D (control) embryo showing the presence of areas of apoptosis in
the liver (right panels), the ventral horns of the spinal cord (middle), and the
lateral ganglionic eminence (left) in the DKO.this process (Chen and Fishman, 2000), including deletion of
miR-1-2 (Zhao et al., 2007). A defective ventricular septum can
be sufficient to cause postnatal lethality, although mice can
sometimes reach adulthood (Sakata et al., 2002). However, in
the case ofmiR-1792 deletion, it is likely that the associated se-
vere lung hypoplasia significantly contributes to the complete
penetrance of neonatal lethality.
The mechanism leading to lung hypoplasia in response to
miR-1792 deletion is presently unclear. Overexpression and
amplification of miR-1792 has been reported in lung cancers
(Hayashita et al., 2005), and antisense inhibition of miR-17 and
miR-20 leads to increased apoptosis in lung cancer cell lines
(Matsubara et al., 2007). It is tempting to speculate that this clus-
ter plays an important role in the proliferation or survival of
normal lung cells. Consistent with this hypothesis is the recent
finding that forced expression of miR-1792 under the control
of a lung-specific promoter leads to hyperproliferation and
blocks differentiation of the lung epithelium in vivo (Lu et al.,
2007).
Role of miR-17w92 in Normal B Cell Development
and Lymphomagenesis
Pro-B cells are the committed B cell progenitors in the bone
marrow and fetal liver. Productive V-DJ rearrangement of the
immunoglobulin heavy chain leads to the assembly of the pre-
B cell receptor (pre-BCR), and signaling via the pre-BCR allows
progression from the pro-B to the pre-B cell stage (Martensson
et al., 2007; Hardy and Hayakawa, 2001). After rearrangement
of the immunoglobulin light chains, the pre-BCR is replaced by
the B cell receptor (BCR), an event that marks the transition to
immature B cells and eventually to mature B cells. Signaling
through the pre-BCR first, and the BCR later, appears to be
required for the survival of B cell precursors and for their progres-
sion through the various stages.
Our results suggest thatmiR-1792 promotes, in a cell-auton-
omous manner, survival of early B cell progenitors. A specific
role for this miRNA cluster in cell survival at the pre-B cell check-
point is also suggested by our finding that its expression is tightly
regulated during B cell development, and it is induced in pre-B
cells. Of note, Koralov and colleagues have demonstrated that
deletion of the miRNA processing enzyme Dicer in lymphocyte
progenitors leads to an arrest at the pro-B to pre-B transition
that is highly reminiscent of what we observe in miR-1792-de-
ficient mice (Koralov et al., 2008 [this issue of Cell]).
Although additional work is required to elucidate the detailed
molecular mechanisms, our results suggest a model for miR-
1792 function in B cell development and in lymphomagenesis.
We propose that miR-1792 expression is induced at the pro-B
to pre-B transition, where it acts to antagonize the expression of
Bim, and possibly additional proapoptotic genes. We also
propose that in the event of overexpression or amplification of
the miR-1792 locus, as it occurs in human B cell lymphomas,
inappropriate suppression of the same proapoptotic gene(s)
facilitates transformation by concomitant oncogenic events.
This model is consistent with the previously published observa-
tion that forced overexpression of miR-1792 cooperates with
the c-Myc oncogene to induce B cell lymphomas by reducing
the degree of apoptosis of lymphoma cells (He et al., 2005).Cell 132, 875–886, March 7, 2008 ª2008 Elsevier Inc. 883
One prediction of this model with potential therapeutic implica-
tions is that inhibition of miR-1792 expression in human diffuse
large B cell lymphomas, and possibly in other tumor types, will
lead to cell death.
Functional Cooperation between miR-17w92
and miR-106bw25
Given their sequence similarity, these three miRNA clusters are
predicted to have a highly overlapping set of targets (Lewis
et al., 2003, 2005; Sethupathy et al., 2006). However, the results
presented in this work demonstrate that only miR-1792 is re-
quired for normal mouse development, while miR-106b25
and miR-106a363 are dispensable. A function for miR-
106b25 is revealed only in the context of miR-1792 loss, as
shown by our analysis of DKO and TKO embryos. Furthermore,
our preliminary results using the conditional miR-1792 allele
show that deletion of a single allele of miR-106b25 synergizes
with miR-1792 deletion in causing a more severe defect in B
cell development (data not shown). Strikingly, the DKO and
TKO embryos not only exhibit increased severity of the defects
observed inmiR-1792 null embryos, but also display additional
defects, in particular apoptosis in specific regions of the central
nervous system and in the liver.
There are several possible explanations for these observa-
tions. For example, expression of these three clusters could be
spatially and temporally segregated. This is probably the case
for miR-106a363 that appears to be expressed at much lower
levels compared to the other two clusters. However, miR-
106b25 and miR-1792 are very similar in terms of both tissue
distribution and expression levels. One potentially relevant dif-
ference between these two clusters is that miR-1792, but not
miR-106b25, expresses members of the miR-19 and miR-18
families (Figures 1A and 1B). It is tempting to speculate that
loss of miR-19a, miR-19b, and miR-18 is largely responsible
for the phenotype caused by deletion of miR-1792.
Bim and Regulation of Cell Death by miR-17w92
and Its Paralogs
It is of great interest to determine the identity of the genes regu-
lated by miR-1792 and its paralogs that are responsible for the
specific defects observed in single and compound mutant ani-
mals. In principle, the complex phenotypes observed in the mu-
tant neonates and embryos could be explained by the effects of
a limited number of target mRNAs. Given the increased cell
death observed in the B cell lineage in singlemiR-1792mutants
and the more widespread apoptosis observed in miR-
1792;miR-106b25 compound mutants, obvious candidates
are proapoptotic genes that have predicted binding sites for mi-
croRNAs belonging to these clusters. Our observation that ex-
pression of the proapoptotic gene Bim is modulated by miR-
1792 is of particular interest in this context. Bim belongs to
the BH3-only family of proapoptotic genes, and its overexpres-
sion leads to apoptosis (Bouillet et al., 2002; O’Connor et al.,
1998). Importantly, Bim is a crucial regulator of leukocyte
homeostasis, as its deletion in mice leads to leukocytosis, with
increased number of circulating B and T cells due to reduced ap-
optosis (Bouillet et al., 1999, 2002).Bim is also an important sup-
pressor of Myc-induced B cell lymphomagenesis (Egle et al.,
2004; Hemann et al., 2005), and its tumor suppressive activity
is dosage sensitive. Even deletion of a single Bim allele leads884 Cell 132, 875–886, March 7, 2008 ª2008 Elsevier Inc.to accelerated Myc-induced lymphomagenesis without loss of
the wild-type allele (Egle et al., 2004). Moreover, Koralov and col-
leagues have shown that that Bim deletion partially rescues the
defective B cell development caused by Dicer (Koralov et al.,
2008). Future work will determine the extent to which Bim dereg-
ulation is responsible for the phenotypes caused by miR-1792
deletion.
In conclusion, we have demonstrated both essential and over-
lapping functions for the miR-1792 family of miRNA clusters.
These results provide new insights into the regulation of critical
developmental processes by miRNAs and indicate an additional
level of control by this class of regulatory molecules in the form of
functional overlap.
EXPERIMENTAL PROCEDURES
ES Cell Manipulation, Generation of Chimeras,
and Tetraploid Blastocyst Complementation
V6.5 ES cells were cultivated on irradiated MEFs in DMEM containing 15%
FBS, leukemia inhibiting factor, penicillin/streptomycin, L-glutamine and non-
essential amino acids.
Targeting constructs were generated by either conventional subcloning
using appropriate restriction enzymes (miR-1792 and miR-106a363) or
by ‘‘recombineering’’ (Liu et al., 2003) (miR-106b25). The constructs were
electroporated in V6.5 embryonic stem cells and cells plated under selective
conditions (2 mg/ml puromycin) 48 hr later. Individual clones were expanded
and tested by Southern blot using probes external to the targeting region.
Clones that had undergone successful homologous recombination were in-
jected into diploid (miR-1792 and miR-106b25 targeting) or tetraploid blas-
tocysts (miR-106a363 targeting) as previously described (Eggan et al., 2001).
Deletion of the floxedmiR-1792 allele was obtained by crossing mice hetero-
zygous for the targeted allele to a Cre-deletor strain (Actin-Cre) (Lewandoski
et al., 1997). Deletion of the Neo cassette was obtained by crossing to
a flpe-deletor mouse (Actin-Flpe) (Rodriguez et al., 2000). Successful recom-
bination was verified by PCR. Primers and protocols for genotyping PCR are
available upon request.
Fetal Liver Reconstitution Experiments
For fetal liver reconstitution experiments, 6- to 8-weeks-old recipient mice
(B6.SJL, Jackson Laboratories) congenic for the CD45.1 allele were irradiated
with 9 Gy and injected retro-orbitally with 43 105–13 106 fetal liver cells from
either wild-type or miR-1792Dneo/Dneo E14.5 embryos. Mice were analyzed
8–10 weeks after transplantation. Peripheral blood was obtained by tail
bleeding.
RNase Protection Assays and qPCR
RNA samples were isolated by homogenizing tissue or cells in Trizol (Invitro-
gen). RNase protection assays were performed using the Ambion miRvana
miRNA detection kit. All probes were purchased from IDT (Supplemental Ex-
perimental Procedures) and end-labeled with NEB Polynucleotide Kinase
and g32P-ATP. qPCR reactions were performed using the Applied Biosystems
miRNA-detection kit. Sno-142 was used for normalization.
Bim 30UTR Reporter Assays
A 165 nucleotide fragment of the Bim 30UTR, including the distal miR-19 and
miR-92 binding sites, was amplified from mouse genomic DNA by PCR using
primer BimUTRfwd and primer BimUTRrev (Supplemental Experimental Pro-
cedures) and cloned into a modified pRL-TK vector. The mutant version was
generated from the wild-type construct by Quikchange multi-site-directed
mutagenesis kit (Promega) according to manufacturers protocol using primers
QCmiR92 and QCmiR19. All constructs were sequenced. For luciferase
assays, 24 hr before transfection 105 HeLa cells were seeded per well in 24-
well plates. Cells were transfected with 100 ng of pGL3 (Promega) and
140 ng of pRL-TK Bim UTR with Lipofectamine 2000 (Invitrogen). Cell were
lysed at 24 or 48 hr, and luciferase activity was measured using Dual luciferase
reporter assay system (Promega) on the Glomax 20/20 luminometer (Prom-
ega). Data are expressed as ratio between Renilla and firefly luciferase activity.
Wild-type Bim luciferase activity was normalized to mutant Bim luciferase
activity.
Antibodies, Immunohistochemistry, and Flow Cytometric Analysis
Four-color and seven-color flow cytometry was performed using FACSCalibur
and LSRII cytometers (BD Biosciences). Cells were sorted on a FacsAria cell
sorter (BD Biosciences). Antibodies were from PharMingen (TCRb, IgD,
Gr-1, CD11b, CD19, CD21, CD23, B220) and eBioscience (c-kit, Sca-1,
IL7R, IgM, Ter119, BP-1, CD5, CD24, CD45.1, CD45.2, CD43, CD71). Perme-
abilization for DAPI staining of DNA content was performed with cytofix/cyto-
perm buffers (BD PharMingen). Annexin V staining was performed with An-
nexin V (BD) in the recommended staining buffer. Flow cytometry data were
analyzed with FlowJo software (TreeStar). The anti-MCM7 antibody was
from Santa Cruz (sc-300). The anti-Bim antibody was a rabbit polyclonal
from Stressgen (AAP-330) and was used at a dilution of 1:1000 for flow cytom-
etry and 1:2000 for western blotting experiments.
Immunohistochemistry was performed on formalin-fixed, paraffin-embed-
ded 4 mm sections using the ABC Vectastain kit. Sections were developed
with DAB and counterstained with hematoxylin. The Cleaved Caspase 3 anti-
body (1:200) was from Cell Signaling.
SUPPLEMENTAL DATA
Supplemental Data include seven figures, Supplemental Experimental Proce-
dures, and Supplemental References and can be found with this article online
at http://www.cell.com/cgi/content/full/132/5/875/DC1/.
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